{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:40:20Z","timestamp":1791398420864,"version":"4.3.3"},"reference-count":52,"publisher":"Wiley","issue":"s1","license":[{"start":{"date-parts":[[2013,12,23]],"date-time":"2013-12-23T00:00:00Z","timestamp":1387756800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2014,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hepatitis has been a major plague of mankind. The history of the discovery of causative viruses is one of the most fascinating scientific adventures of this half century. Individualization of several types of hepatitis only emerged after world war two. Their identification has been associated with milestones which revolutionized medicine and public health. The discovery of HBV brought the first ever vaccine not prepared by tissue culture but initially directly from plasma and soon the first vaccine produced by genetic engineering. HBV vaccine proved to be the first \u201canti\u2010cancer\u201d vaccine by preventing hepatocellular carcinoma and practically eradicating it from childhood in Taiwan. Successful vaccines became also available for HAV and more recently HEV. The discovery of HCV in 1989 opened a new era since it was the first virus was identified by a direct molecular approach. Two billion people are infected with HBV and 350 million are chronic carriers of the virus. The extraordinary effectiveness of HBV vaccination was best illustrated in Taiwan and Singapore where in less than 2 decades HBs Ag carriers dropped from 9,1% to 2,7% and HCC from 27% to 17%. Successful development of nucleos(t)ides analogs make it now possible to fully control disease progression with a daily pill long term therapy. The progress in HCV therapy has been even more spectacular and successful treatment jumped from 6 % with interferon alone in 1986 to more than 80% in 2013 with triple combination therapies. Remarkably chronic hepatitis C is the only chronic disease which is curable. It will be soon possible to eradicate HCV infection with, an all oral, daily single pill (containing several molecules) for 3 to 6 months which will cure over 90% of patients. This unprecedented therapeutic victory benefiting hundred millions of people matches the triumphs over small pox, polio and tuberculosis. The next 10 years should undoubtedly witness cure or full control over all forms of acute and chronic hepatitis.<\/jats:p>","DOI":"10.1111\/liv.12409","type":"journal-article","created":{"date-parts":[[2013,12,23]],"date-time":"2013-12-23T07:49:39Z","timestamp":1387784979000},"page":"29-37","source":"Crossref","is-referenced-by-count":79,"title":["A brief history of hepatitis milestones"],"prefix":"10.1111","volume":"34","author":[{"given":"Christian","family":"Trepo","sequence":"first","affiliation":[{"name":"Hepatology Unit CROIX ROUSSE Hospital and INSERM U1052 Lyon France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,12,23]]},"reference":[{"key":"e_1_2_12_2_1","volume-title":"De la jaunisse \u00e0 l'h\u00e9patite C, 5000 ans d'histoire","author":"Payen JL","year":"2002"},{"key":"e_1_2_12_3_1","first-page":"2097","article-title":"Histoire des h\u00e9patites. I. De la jaunisse au virus","volume":"52","author":"Payen JL","year":"2002","journal-title":"Rev Prat"},{"key":"e_1_2_12_4_1","first-page":"279","article-title":"Viral hepatitis \u2010 The silent killer","volume":"41","author":"Oon GCJ","year":"2012","journal-title":"Annals Academy of Medicine"},{"key":"e_1_2_12_5_1","first-page":"281","article-title":"Viral Hepatitis","volume":"3","author":"Tygstrup N","year":"1980","journal-title":"Clinics in Gastroenterology"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198704163161601"},{"key":"e_1_2_12_7_1","first-page":"691","article-title":"Homologous serum hepatitis","volume":"2","author":"MacCallum F","year":"1947","journal-title":"Lancet"},{"key":"e_1_2_12_8_1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jama.1967.03120180053006","article-title":"Infectious hepatitis \u2010 Evidence for two distinctive clinical, epidemiological, and immunological type of infection","volume":"200","author":"Krugman S","year":"1967","journal-title":"JAMA"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1984.03350030061023"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26787"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1965.03080070025007"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.60.3.814"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(70)90926-8"},{"key":"e_1_2_12_14_1","volume-title":"Hepatitis B: The hunt for a killer virus","author":"Blumberg BS","year":"2003"},{"key":"e_1_2_12_15_1","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.4049\/jimmunol.109.5.1017","article-title":"New specificities in Australia antigen positive sera distinct from the \u2018Le Bouvier\u2019 determinants","volume":"109","author":"Magnius L","year":"1972","journal-title":"J Immunology"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(86)90395-1"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)90713-7"},{"key":"e_1_2_12_18_1","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.1128\/jvi.67.9.5402-5410.1993","article-title":"Hepatitis B virus genotype A rarely circulates as an HBe\u2010minus mutant: possible contribution of a single nucleotide in the precore region","volume":"67","author":"Li JS","year":"1993","journal-title":"J Virol"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.06.007"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1386-6532(05)80005-8"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26428"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26560"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.18.12.997"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)90261-A"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0037-86821992000300001"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.125.4.673"},{"key":"e_1_2_12_27_1","first-page":"365","article-title":"Hepatitis A: detection by immune electron microscopy of virus like antigen associated with acute illness","volume":"200","author":"Feinstone SM","year":"1973","journal-title":"Science"},{"key":"e_1_2_12_28_1","first-page":"2416","article-title":"Long incubation post transfusion hepatitis without serological evidence of exposure to hepatitis B virus","volume":"2","author":"Prince A","year":"1974","journal-title":"Lancet"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197504102921502"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(85)90150-7"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2523562"},{"issue":"1","key":"e_1_2_12_32_1","first-page":"1","article-title":"Epidemiology: infectious hepatitis in Dehli 1955\u201056","volume":"45","author":"Wiewanath R","year":"1957","journal-title":"Indian J Med Res"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(80)92045-0"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a113643"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1159\/000149370"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/159.6.1042"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1971.03190240019005"},{"key":"e_1_2_12_38_1","first-page":"429","article-title":"Prevention of virus B hepatitis (SH hepatitis)","volume":"123","author":"Soulier JP","year":"1972","journal-title":"Am J Dis Child"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198010093031501"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(81)90585-7"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI103164"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(69)90243-5"},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198102123040702"},{"key":"e_1_2_12_44_1","first-page":"42","article-title":"Treatment of chronic anti\u2010HBe\u2010positive hepatitis B with interferon\u2010alpha","volume":"22","author":"Brunetto MR","year":"1995","journal-title":"J Hepatol"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199910213411702"},{"key":"e_1_2_12_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(71)91883-6"},{"key":"e_1_2_12_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/9781118637272.ch11"},{"key":"e_1_2_12_48_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198612183152503"},{"key":"e_1_2_12_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(90)90161-J"},{"key":"e_1_2_12_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)91707-2"},{"key":"e_1_2_12_51_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.26371"},{"key":"e_1_2_12_52_1","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alpha\u20102b plus ribavirin compared with interferon alpha\u20102b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial","volume":"358","author":"Manns MP","year":"2001","journal-title":"Lancet"},{"key":"e_1_2_12_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2009.01246.x"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fliv.12409","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fliv.12409","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/liv.12409","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T23:24:01Z","timestamp":1694561041000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/liv.12409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,23]]},"references-count":52,"journal-issue":{"issue":"s1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["10.1111\/liv.12409"],"URL":"https:\/\/doi.org\/10.1111\/liv.12409","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,23]]}}}